Tellurides Bearing Sulfonamides as Novel Inhibitors of Leishmanial Carbonic Anhydrase with Potent Antileishmanial Activity

J Med Chem. 2020 Apr 23;63(8):4306-4314. doi: 10.1021/acs.jmedchem.0c00211. Epub 2020 Apr 9.

Abstract

We report for the first time a novel series of tellurides bearing sulfonamide as selective and potent inhibitors of the β-class carbonic anhydrase (CA; EC 4.2.1.1) enzyme expressed in Leishmania donovani protozoa. Such derivatives showed high activity against axenic amastigotes, and among them, compound 5g (4-(((3,4,5-trimethoxyphenyl)tellanyl)methyl)benzenesulfonamide) showed an IC50 of 0.02 μM being highly selective for the parasites over THP-1 cells with a selectivity index of 300. The in vitro and in vivo toxicity experiments showed compound 5g to possess a safe profile and thus paving the way for tellurium-containing compounds as novel drug entities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbonic Anhydrase Inhibitors / chemistry
  • Carbonic Anhydrase Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Female
  • Jejunum / drug effects
  • Jejunum / pathology
  • Leishmania donovani / drug effects*
  • Leishmania donovani / physiology
  • Organ Culture Techniques
  • Rats
  • Rats, Wistar
  • Sulfonamides / chemistry
  • Sulfonamides / pharmacology*
  • Trypanocidal Agents / chemistry
  • Trypanocidal Agents / pharmacology*

Substances

  • Carbonic Anhydrase Inhibitors
  • Sulfonamides
  • Trypanocidal Agents